jRCT2080221056未知1 期
PhaseI study with multiple, ascending doses of NA808 in patients with chronic hepatitis C viral infection.
试验速览
- 阶段
- 1 期
- 入组人数
- 20
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open-label, multicenter study
入排标准
- 年龄范围
- 20age old over 至 70age old under（—）
- 性别
- All
入选标准
- •Subject shows detectable HCV RNA and has no clinically significant disorders.
- •Male or female of no child-bearing potential
排除标准
- 未提供
结局指标
主要结局
-
Safety Pharmacokinetics HCV-RNA viral kinetics
次要结局
未报告次要终点
研究者
相似试验
未知
1 期
A808 PhaseI multiple ascending doses studyPatients with chronic hepatitis C viral infectionJPRN-jRCT2080221056Chugai Pharmaceutical Co., Ltd.20
招募中
1 期
A Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of SZN-043, a Novel Bispecific Fusion Protein Targeting ASGR1 and ZNRF3/RNF43, in Healthy Volunteers and Subjects with Liver CirrhosisAlcoholic HepatitisInflammatory and Immune System - Other inflammatory or immune system disordersLiver CirrhosisACTRN12622000392763Surrozen Operating, Inc.40
已完成
1 期
A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ALG-801 in Healthy Postmenopausal WomeBone lossMuscle wastingMusculoskeletal - Normal musculoskeletal and cartilage development and functionMusculoskeletal - OsteoporosisACTRN12623000204640AliveGen USA, Inc.32
已完成
1 期
Phase I Single- and Multiple-Ascending Dose Trial of EVX-101Mental and Behavioural DisordersDepressionISRCTN42835524Evecxia Therapeutics Inc.38
进行中（未招募）
1 期
A Phase 1/2 Study of ACN00177 in Subjects With Homocystinuria Due to Cystathionine ß-Synthase (CBS) DeficiencyHomocystinuria Due to Cystathionine ß-Synthase (CBS) DeficiencyMedDRA version: 20.0Level: PTClassification code 10020365Term: HomocystinuriaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2019-004791-19-GBAeglea Biotherapeutics, Inc.25